Earn 10 pts/$1 + 500 bonus points on signup|
EPO - Front - MiPeptidos
Specialty / Research

EPO

CAS: 11096-26-7 (erythropoietin); 113427-24-0 (epoetin alfa)

Anemia treatment (chronic kidney disease, chemotherapy-induced) · Erythropoiesis and red blood cell production · Tissue protection and neuroprotection

EPO is a glycoprotein hormone produced primarily by peritubular interstitial cells in the kidney in response to hypoxia.

  • Anemia treatment (chronic kidney disease, chemotherapy-induced)
  • Erythropoiesis and red blood cell production
  • Tissue protection and neuroprotection
  • Endurance and oxygen-carrying capacity
Research Use Only.

This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.

Frequently Bought Together

Bacteriostatic Water

Bacteriostatic Water

Required for reconstitution

$10.00
AICAR

AICAR

Specialty / Research

$40.00
Starting at
$50.00/vial
In Stock
Ships same day
Vials1
Earn 500 pts
≥99% HPLC| COA Included| Ships Today
≥99% Purity
COA Included
Third-Party Tested
Same-Day Shipping
EPO Brochure
Free download — PDF format
ProtocolsHPLC DataDosingEN + ES

No spam. Unsubscribe anytime.

HPLC Purity Analysis

High-Performance Liquid Chromatography
99.5%purity
mAURetention Time (min)0250500750100005101520253099.5%
Method: RP-HPLC C18UV 220nmACN/H₂O + 0.1% TFA
CoA Included
HPLC Verified
GMP Compliant
Third-Party Tested
Same-Day Shipping
Batch Tracked

Specifications

Purity
≥99%
Form
Lyophilized Powder
CAS
11096-26-7 (erythropoietin); 113427-24-0 (epoetin alfa)
Mol. Weight
~30,400 Da (glycosylated form); 18,400 Da (protein backbone only)

How EPO Works

EPO is a glycoprotein hormone produced primarily by peritubular interstitial cells in the kidney in response to hypoxia. It binds to the erythropoietin receptor (EPOR) on erythroid progenitor cells in bone marrow, activating JAK2/STAT5, PI3K/Akt, and MAPK signaling cascades. This prevents apoptosis of erythroid precursors and stimulates their proliferation and differentiation into mature red blood cells (erythropoiesis). EPO also has tissue-protective effects mediated through the EPOR/betacR heterodimer in non-hematopoietic tissues (brain, heart, kidney).

Research Applications

1
Anemia treatment (chronic kidney disease, chemotherapy-induced)
2
Erythropoiesis and red blood cell production
3
Tissue protection and neuroprotection
4
Endurance and oxygen-carrying capacity
5
Hypoxia sensing and HIF pathway biology

Pricing

SizePer Vial10-Pack
3000iu
$50.00$500.00

10-pack pricing shown. Volume discounts for 50+ vials — contact us.

Certificate of Analysis

MiPeptidos
EPO
PASSES ALL SPECIFICATIONS
Batch NumberHR-EPO-2600115
Date of AnalysisMarch 13, 2026
Purity (HPLC)99.5%
AppearanceWhite to off-white lyophilized powder
SolubilityFreely soluble in sterile water and bacteriostatic water
Molecular Weight (MS)~30,400 Da (glycosylated form); 18,400 Da (protein backbone only) — Confirmed
Endotoxin (LAL)<0.1 EU/mg
Sterility (USP <71>)Passes USP <71>

This COA is a representative sample. A batch-specific Certificate of Analysis with full HPLC chromatograms and mass spectrometry data is included with every order.

Research Use Only. This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.